thromboplastin and beraprost

thromboplastin has been researched along with beraprost* in 1 studies

Other Studies

1 other study(ies) available for thromboplastin and beraprost

Article	Year
Effect of TRK-100, a prostacyclin analogue, on endotoxin-induced enhancement of blood coagulation in rats. Japanese journal of pharmacology, 1989, Volume: 51, Issue:3 TRK-100 (0.03, 0.1 and 0.3 mg/kg, p.o.), a chemically stable analogue of prostacyclin, dose-dependently prevented blood coagulation and glomerular fibrin deposition which were enhanced by 4 hr infusion of endotoxin (100 mg/kg) in rats. In addition, TRK-100 suppressed the generation of endotoxin-induced tissue thromboplastin like activity in cultured human endothelial cells. Topics: Administration, Oral; Animals; Blood Coagulation; Dose-Response Relationship, Drug; Endotoxins; Epoprostenol; Humans; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Thromboplastin	1989

Article

Year

Effect of TRK-100, a prostacyclin analogue, on endotoxin-induced enhancement of blood coagulation in rats.

Japanese journal of pharmacology, 1989, Volume: 51, Issue:3

TRK-100 (0.03, 0.1 and 0.3 mg/kg, p.o.), a chemically stable analogue of prostacyclin, dose-dependently prevented blood coagulation and glomerular fibrin deposition which were enhanced by 4 hr infusion of endotoxin (100 mg/kg) in rats. In addition, TRK-100 suppressed the generation of endotoxin-induced tissue thromboplastin like activity in cultured human endothelial cells.

Topics: Administration, Oral; Animals; Blood Coagulation; Dose-Response Relationship, Drug; Endotoxins; Epoprostenol; Humans; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Thromboplastin

1989